Home » Topics » BioWorld Science

BioWorld Science
RSS

CoCensys and MGH expand license for migraine treatment technology

Jan. 8, 1998

Company Profile: Shaman

Jan. 8, 1998

Efficacy of muscle relaxant established in preclinical models

Jan. 8, 1998

Yamanouchi: Six-month 1998 highlights

Jan. 8, 1998

BioChem Pharma/Scriptgen conclude licensing and equity agreements

Jan. 8, 1998

PLA2 inhibitors described by Santen

Jan. 8, 1998

New antifungal antibiotic TKR-842 from Takara Shuzo

Jan. 8, 1998

New carbapenems in development at Takeda

Jan. 8, 1998

Interneuron: FY 1997 highlights

Jan. 8, 1998

COX-2 inhibitors under study at Abbott

Jan. 8, 1998

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
AA meeting of minds as PTC, Novartis push votoplam in HD
BioWorld
What PTC Therapeutics Inc.’s latest data with votoplam might mean in the Huntington’s disease (HD) landscape became grist for Wall Street after the firm unveiled...